AMRX Competitors & Alternatives
Compare Amneal Pharmaceuticals, Inc. Class A Common Stock with similar stocks in the same industry
Drug Manufacturers - Specialty & Generic
AMRX
Main Stock$17.91
Tradestie Score
60
Market Cap
$3.26B
P/E Ratio
38.1
Revenue Growth
0.1%
Analyst Upside
+15.9%
Top Competitors
45 stocks in Drug Manufacturers - Specialty & Generic| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RGC
Regencell Bioscience Holdings Limited Ordinary Shares
|
$5.30
|
$7.83B | - | 50 | Compare |
|
ALKS
Alkermes Inc. plc
|
$48.33
|
$5.06B | 129.8 | 55 | Compare |
|
PTGX
Protagonist Therapeutics, Inc
|
$154.32
|
$3.98B | 153.4 | 43 | Compare |
|
LNTH
Lantheus Holdings, Inc
|
$99.97
|
$3.51B | 24.0 | 56 | Compare |
|
PBH
Prestige Consumer Healthcare Inc.
|
$51.31
|
$3.12B | 14.5 | 41 | Compare |
|
PRGO
PERRIGO COMPANY PLC
|
$14.25
|
$3.10B | - | 26 | Compare |
|
INDV
Indivior PLC Ordinary Shares
|
$36.87
|
$2.93B | 13.5 | 59 | Compare |
|
KNSA
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares
|
$79.03
|
$2.86B | 81.7 | 44 | Compare |
|
HCM
HUTCHMED (China) Limited American Depositary Shares
|
$12.63
|
$2.74B | 125.6 | 35 | Compare |
|
SUPN
Supernus Pharmaceuticals, Inc.
|
$45.85
|
$2.69B | - | 51 | Compare |
More AMRX Analysis
Data updated: Aug 23, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)
45 stocks in this industry